Any way you look at it, the last five years have been atrocious for Aurora Cannabis (ACB 1.09%).Shares of the Canadian cannabis company plunged nearly 99.7% below the high set in the first half of ...

Shares of Aurora Cannabis reached a low of $0.60 on March 18, 2020. If you invested $15,000 in the stock back then, you would have owned 25,000 shares of the cannabis company -- until its reverse ...

Aurora Cannabis sees 29% YoY growth and solid cash flow, unaffected by U.S. market fears. Read why ACB stock remains a solid buy despite recent volatility.

Aurora's net revenue totaled 83.4 million Canadian dollars ($60.7 million) for the first quarter of fiscal 2025, which ended on June 30. It was a 12% increase from the same period last year.

Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB:CA) is set to report its fourth quarter and full fiscal year 2025 earnings this coming Wednesday before market open.The company is at a pivotal moment in ...

Aurora’s medical cannabis segment experienced a robust 13.5% growth, with revenues reaching C$47.2 million. This growth offset a 10% decline in consumer cannabis revenue, which fell to C$11.5 ...

In its third-quarter results of fiscal 2025, Aurora’s medical cannabis revenues rose 51% year over year to C$68.1 million. Revenues from this segment accounted for more than 75% of ACB’s total ...

Last quarter, Aurora Cannabis reported just a 5% increase in its top line, compared to the prior-year period, with sales climbing to CA$67.4 million.

Aurora's medical-cannabis business is a bright spot for the company. Medical sales increased 9% in the most recent quarter, while the company's recreational sales tumbled 45%.

Aurora Cannabis shares tumbled Wednesday as the Canadian cannabis operator said it expects “temporary declines” in its international markets, which include the U.S. ...

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce the Company's discovery of a novel source of genetic resistance ...

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) has reached an agreement to acquire all of the issued and outstanding shares of TerraFarma Inc., the parent company of Thrive Cannabis.